Type I NKT cell-deficient Jα18 knockout (KO) mice and NKT cell-deficient CD1d KO mice were both shown to have faster tumor growth compared to wild-type mice with intact NKT cells in a fibrosarcoma model, suggesting that type I NKT cells facilitate tumor immunosurveillance [92]. Here, CD1D is linked to neoplasm.